कृपया अन्य खोज का प्रयास करें
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. The company is also developing ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma for treating other CD70+ solid tumor and hematological malignancies indications. The company was founded in 2014 and is based in Boston, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Jeffrey Allan Chodakewitz | 69 | 2020 | Independent Director |
Steve Dubin | 70 | 2020 | Independent Director |
Chen Schor | 52 | 2020 | CEO, President & Director |
Aya Jakobovits | 68 | 2020 | Founder & Independent Director |
Alice Bertaina | - | 2021 | Member of Scientific Advisory Board |
Michael Glen Kauffman | 61 | 2021 | Independent Director |
Saul Priceman | - | 2021 | Member of Scientific Advisory Board |
Marco L. Davila | - | 2021 | Member of Scientific Advisory Board |
Carl L. Gordon | 59 | 2020 | Independent Chairman |
Andrew Sinclair | 52 | 2021 | Independent Director |
Constantine Mitsiades | - | 2021 | Member of Scientific Advisory Board |
Lloyd Klickstein | 67 | 2020 | Member of Scientific Advisory Board |
Michael Kalos | - | 2021 | Member of Scientific Advisory Board |
Katie Peng | - | 2023 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है